Blue Light Treatment for MRSA

blue550

Drug-resistant infections like MRSA (Methicillin-resistant Staphylococcus aureus) are on the rise. MRSA infections most commonly occur in health care settings and are often associated with invasive procedures. The increase in MRSA infections is attributed to antibiotic overuse, including the unnecessary use and the widespread practice of feeding antibiotics to livestock to promote growth and reduce infections in factory farm conditions.

According to Dr. Joseph Mercola, MRSA infections can be effectively treated with blue light therapy, as documented in two studies published in 2009 and most recently in 2012 which found that, "Blue light is a potential non-toxic, non-antibiotic approach for treating skin and soft tissue infections, especially those caused by antibiotic resistant pathogens."

This research could point to a new drug-free direction in the treatment of antibiotic-resistant infections. Because blue light therapy was approved by the FDA more than a decade ago for the treatment of severe acne, the technology is already commercially available.